Einride to Participate in Upcoming Investor Conferences

STOCKHOLM, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Einride AB (Nasdaq: ENRD), a leader in digital, electric, and autonomous freight mobility, today announced that Einride management will participate in the following upcoming investor events.

Evercore 9th Annual ADAS, AV & AI Forum
Location: New York, NY
Date: September 29, 2026

J.P. Morgan U.S. Opportunities Forum
Location: Miami, FL
Date: November 12–13, 2026

UBS 30th Annual Global Technology and AI Conference
Location: Scottsdale, AZ
Date: November 30–December 3, 2026

UBS Global Industrials and Transportation Conference
Location: Manalapan, FL
Date: November 30–December 3, 2026

On occasion, Einride may choose to webcast its participation in a question-and-answer session hosted by the applicable host firm’s research analyst. More details will be available on the Company’s investor relations website as they become available.

Institutional investors can contact their sales representative at each hosting organization to register and request a meeting.

About Einride
Founded in Stockholm in 2016, Einride (Nasdaq: ENRD) is a technology leader driving the transition to sustainable, cost-efficient autonomous and electric freight operations. The company's platform integrates AI-powered freight intelligence, proprietary autonomous technology, and one of the world's largest electric heavy-duty fleets. Einride serves a global customer base across North America, Europe, and the Middle East through a dual business model encompassing Freight-Capacity-as-a-Service (FCaaS) and a Software-as-a-Service (SaaS) platform.

Investor Relations Contact
Eduardo Royes, ICR
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/00e96728-034e-4ff2-8834-03464b5a4979

Einride Autonomous Vehicles

Two of Einride's autonomous vehicles operating in Selmer, Tennessee.

You May Also Be Interested In

• California Creates Landmark Dementia Registry as Governor Newsom Signs SB 1047 Into Law
• Jenny McCarthy Begins Therapeutic Plasma Exchange Journey to Address Mold Toxicity and Environmental Toxins
• Southport Acquisition Corp. II Announces Pricing of $200,000,000 Initial Public Offering